Notice Information
Notice Title
MHRA specials licenced manufacturing facility
Notice Description
The North East and North Cumbria (NENC) Provider Collaborative is a formal partnership of all 11 NHS Foundation Trusts (FTs) in the region. Together it covers the entire geographical footprint of the NENC Integrated Care System, from North Yorkshire up to the Scottish borders, and provides the vast majority of all secondary NHS care services with millions of patient interactions every single day. The NENC Provider Collaborative proposes in this pre market engagement document is to establish a NENC aseptics pharmaceutical production hub at Seaton Delaval, as part of a hub and spoke model, with four initial key priority areas: 1. Injectable chemotherapy medicines supply 2. Addressing nursing time currently spent preparing injectable medicines (primarily Ready to Administer (RtA) injectable antibiotic medicines to clinical areas) 3. Parenteral nutrition production 4. Provision of centralised over labelling of medicines This will deliver substantial benefits improving clinical safety, delivering a reliable supply of products for patient use, freeing up capacity on hospital sites and directly releasing significant nursing time for patient care. NENC PC are looking to assess the feasibility of establishing an MHRA specials licenced manufacturing facility capable of meeting GMP, quality and operational requirements. The proposed output of this facility will be: * 950,000 Ready to Administer (RtA) products * 70,000 Systemic anti-cancer therapies and Monoclonal antibodies * 70,000 Parenteral Nutrition products. * 400,000 - 600,000 over labelled products. NHFM is conducting a preliminary market consultation in accordance with the Public Contracts Regulations 2015 reg. 40 with interested organisations to be held on the 10th and 14th February 2023 details of which can be downloaded from the NHFM e-tender Portal https://procontract.due-north.com reference number DN652731 Following the event companies will be required to complete a questionnaire which must be returned via the NHFM e tender portal no later that 12:00 Noon on 24/2/23.
Lot Information
Lot 1
The NENC PC are looking to assess the feasibility of establishing an MHRA specials licenced manufacturing facility capable of meeting GMP, quality and operational requirements. The proposed output of this facility will be: * 950,000 Ready to Administer (RtA) products * 70,000 Systemic anti-cancer therapies and Monoclonal antibodies * 70,000 Parenteral Nutrition products. * 400,000 - 600,000 over labelled products.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0399ed
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/002070-2023
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33000000 - Medical equipments, pharmaceuticals and personal care products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 23 Jan 20233 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 30 Apr 2023Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planned
- Lots Status
- Planned
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST
- Contact Name
- Mr Kevin Marshall
- Contact Email
- kevin.marshall@northumbria-healthcare.nhs.uk
- Contact Phone
- +44 150129
Buyer Location
- Locality
- NEWCASTLE UPON TYNE
- Postcode
- NE27 0QJ
- Post Town
- Newcastle upon Tyne
- Country
- England
-
- Major Region (ITL 1)
- TLC North East (England)
- Basic Region (ITL 2)
- TLC4 Northumberland, Durham and Tyne & Wear
- Small Region (ITL 3)
- TLC43 Tyneside
- Delivery Location
- TLC North East (England)
-
- Local Authority
- North Tyneside
- Electoral Ward
- Shiremoor
- Westminster Constituency
- Tynemouth
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0399ed-2023-01-23T17:59:32Z",
"date": "2023-01-23T17:59:32Z",
"ocid": "ocds-h6vhtk-0399ed",
"initiationType": "tender",
"tender": {
"id": "DN652731",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "MHRA specials licenced manufacturing facility",
"status": "planned",
"classification": {
"scheme": "CPV",
"id": "33000000",
"description": "Medical equipments, pharmaceuticals and personal care products"
},
"mainProcurementCategory": "goods",
"description": "The North East and North Cumbria (NENC) Provider Collaborative is a formal partnership of all 11 NHS Foundation Trusts (FTs) in the region. Together it covers the entire geographical footprint of the NENC Integrated Care System, from North Yorkshire up to the Scottish borders, and provides the vast majority of all secondary NHS care services with millions of patient interactions every single day. The NENC Provider Collaborative proposes in this pre market engagement document is to establish a NENC aseptics pharmaceutical production hub at Seaton Delaval, as part of a hub and spoke model, with four initial key priority areas: 1. Injectable chemotherapy medicines supply 2. Addressing nursing time currently spent preparing injectable medicines (primarily Ready to Administer (RtA) injectable antibiotic medicines to clinical areas) 3. Parenteral nutrition production 4. Provision of centralised over labelling of medicines This will deliver substantial benefits improving clinical safety, delivering a reliable supply of products for patient use, freeing up capacity on hospital sites and directly releasing significant nursing time for patient care. NENC PC are looking to assess the feasibility of establishing an MHRA specials licenced manufacturing facility capable of meeting GMP, quality and operational requirements. The proposed output of this facility will be: * 950,000 Ready to Administer (RtA) products * 70,000 Systemic anti-cancer therapies and Monoclonal antibodies * 70,000 Parenteral Nutrition products. * 400,000 - 600,000 over labelled products. NHFM is conducting a preliminary market consultation in accordance with the Public Contracts Regulations 2015 reg. 40 with interested organisations to be held on the 10th and 14th February 2023 details of which can be downloaded from the NHFM e-tender Portal https://procontract.due-north.com reference number DN652731 Following the event companies will be required to complete a questionnaire which must be returned via the NHFM e tender portal no later that 12:00 Noon on 24/2/23.",
"lots": [
{
"id": "1",
"description": "The NENC PC are looking to assess the feasibility of establishing an MHRA specials licenced manufacturing facility capable of meeting GMP, quality and operational requirements. The proposed output of this facility will be: * 950,000 Ready to Administer (RtA) products * 70,000 Systemic anti-cancer therapies and Monoclonal antibodies * 70,000 Parenteral Nutrition products. * 400,000 - 600,000 over labelled products.",
"status": "planned"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKC"
}
],
"deliveryLocation": {
"description": "The intended location of the facility is the North East and North Cumbria Manufacturing Facility, Northumbria Healthcare NHS manufacturing and innovation hub, Seaton Delaval, Northumberland."
},
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2023-05-01T00:00:00+01:00"
},
"participationFees": [
{
"id": "1",
"type": [
"document"
]
}
],
"coveredBy": [
"GPA"
]
},
"parties": [
{
"id": "GB-FTS-54285",
"name": "Northumbria Healthcare NHS Foundation Trust",
"identifier": {
"legalName": "Northumbria Healthcare NHS Foundation Trust"
},
"address": {
"streetAddress": "Northumbria House, Unit 7/8 Silverfox Way",
"locality": "Newcastle Upon Tyne",
"region": "UKC",
"postalCode": "NE27 0QJ",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Mr Kevin Marshall",
"telephone": "+44 150129",
"email": "kevin.marshall@northumbria-healthcare.nhs.uk",
"url": "https://procontract.due-north.com"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.northumbria.nhs.uk",
"buyerProfile": "https://www.northumbria.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
}
],
"buyer": {
"id": "GB-FTS-54285",
"name": "Northumbria Healthcare NHS Foundation Trust"
},
"language": "en"
}